報價延遲最少15分鐘:2025/07/06 17:47 EDT
|
|
|
|
|
||||||||||||
|
|
|
|
|
33.23 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-1.55/0.99
|
|
企業價值
1.56B
|
| 資產負債 |
|
每股賬面淨值
37.17
|
| 現金流量 |
|
現金流量率
0.05
|
| 損益表 |
|
收益
656.32M
|
|
每股收益
13.77
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘：2025/07/06 17:47 EDT
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| Azenta Inc is a provider of life sciences solutions, enabling impactful breakthroughs and therapies to market faster. It provides a full suite of reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally. The company has three reportable segments that are Sample Management Solutions, Multiomics, and B Medical Systems. It generates a substantial part of its revenue from its Sample Management Solutions segment. |